Your browser doesn't support javascript.
loading
Yindan Jiedu granules exhibit anti-inflammatory effect in patients with novel Coronavirus disease (COVID-19) by suppressing the NF-κB signaling pathway.
Feng, Ying; Zhu, Bingbing; Liu, Yao; Liu, Yao; Zhou, Guiqin; Yang, Li; Liu, Long; Ren, Jie; Hou, Yixin; Yu, Hao; Meng, Peipei; Jiang, Yuyong; Wang, Xianbo.
Afiliación
  • Feng Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Zhu B; Department of Gastroenterology, The Third Affiliated Hospital, Beijing University of Chinese Medicine, Beijing 100029, China.
  • Liu Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Liu Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Zhou G; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Yang L; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Liu L; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Ren J; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Hou Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Yu H; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Meng P; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China.
  • Jiang Y; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address: jyuy11@126.com.
  • Wang X; Department of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China. Electronic address: wangxb@ccmu.edu.cn.
Phytomedicine ; 95: 153784, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34785108

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: FN-kappa B / COVID-19 Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Phytomedicine Asunto de la revista: TERAPIAS COMPLEMENTARES Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Alemania